Science is fun

POSTS ABOUT NEWS

REKOM BIOTECH signs a distribution agreement for United Kingdom and Ireland

7/27/2021

2B Scientific Agreement

We are pleased to announce our new distribution partnership with 2B Scientific Ltd. On July 27th, our company sealed an exclusive distribution agreement for the commercialization of our products throughout the United Kingdom and Ireland.

(...)

View more

CATEGORY: NEWS

Rekom Biotech receives a special mention in the XII Awards for Excellence in Andalusian SMEs

7/14/2021

XII Awards for Excellence in Andalusian SMEs

The Awards for Excellence in Andalusian SMEs, organized by Caixabank and Grupo Joly, were created to give visibility to the reality that Andalusia has an excellent network of SMEs and, in many cases, they are leaders in their sector and are completely focused on the international market.

(...)

View more

CATEGORY: NEWS

REKOM BIOTECH implements the ISO 13485 standard

7/9/2021

9th February, 2022, will be the date when the IVD manufacturers will have to adjust their business from the requirements of IVD Directive to the IVD Regulation (EU) 2017/746. This regulation provides a modern regulatory framework to the operators of the IVD market, including suppliers that provide critical products such as raw material for the in vitro diagnostic medical devices.

(...)

View more

CATEGORY: NEWS

Rekom Biotech is listed as one of the top ten leading vendors in the Insight Partners' Viral Antigens Market Forecast to 2027 report

1/9/2021

The Insight Partners makes reports that provide in-depth analysis on the selected topic, making a review of the most important companies in the sector, and restraints and opportunities available in the market.

The Viral Antigens Market Forecast to 2027 report provides a study of Viral Antigens market using SWOT analysis (Strength, Weakness, Opportunities and Threat to the organization), and also provides an in-depth survey of the key players in the market. This survey is based on various objectives of an organization, such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization. Rekom Biotech appears as one of the ten top leading vendors of the Viral Antigens market.

(...)

View more

CATEGORY: NEWS

Rekom Biotech's antigen for COVID-19 is ready to support India for rapid and effective detection of this disease

9/7/2020

On this critical COVID-19 pandemic times, each social agent must give its best and show social commitment. Our best way to support the health world in this situation is with our recombinant nucleoprotein antigen for SARS-CoV (NP-CTD), the most trustable method for a fast and effective COVID-19 early detection.

We are happy to announce that Rekom Biotech will be a supplier of raw material for COVID-19 detection to the Indian company whose Covid IgG ELISA kit is approved by the Indian government.